Highline Wealth Partners’s Chemours CC Stock Holding History

Highline Wealth Partners’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-9	Closed	-$122	–	922
2025 Q1	$122	Buy	+9	New	+$149	﹤0.01%	986

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AWAM

Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Highline Wealth Partners's CC Position: Q2 2025 in Review

Highline Wealth Partners sold out of Chemours (CC) in Q2 2025, closing a stake of 9 shares — an estimated $122 sold.

Highline Wealth Partners first reported a position in CC in Q1 2025 and held it in 1 quarter. The position peaked at $122 in Q1 2025. 434 funds tracked by Wall St. Rank hold CC as of Q2 2025.

Highline Wealth Partners reported no remaining Chemours position as of Q2 2025 after selling out during the quarter.
Highline Wealth Partners sold 9 Chemours shares in Q2 2025, an estimated $122.
Highline Wealth Partners first reported a position in Chemours in Q1 2025 and held it in 1 quarter.
Highline Wealth Partners's Chemours position peaked at $122 in Q1 2025.
434 funds tracked by Wall St. Rank held Chemours as of Q2 2025.

Based on Highline Wealth Partners's 13F filing for Q2 2025, filed 16 Jul 2025.